A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

Autor: Ouédraogo, Alphonse, Kargougou, Désiré, Nébié, Issa, Débé, Siaka, Diarra, Amidou, Bougouma, Edith, Hounkpatin, Aurore B., Adegnika, Ayola Akim, Lell, Bertrand, Joanny, Fanny, Honkpehedji, Yabo Josiane, Agobe, Jean Claude Dejon, Esen, Meral, Ajua, Anthony, Asoala, Victor, Anyorigiya, Thomas, Ansah, Nana Akosua, Buwembo, William, Mworozi, Edison, Sekikubo, Musa, Abubakar, Ismaela, Bojang, Kalifa, Noor, Ramadhani, Okech, Brenda, Ejigu, Dawit A., Sirima, Sodiomon B., Mordmüller, Benjamin, Milligan, Paul, Ngoa, Ulysse Ateba, Kironde, Fred, Atuguba, Frank, Tiono, Alfred B., Issifou, Saadou, Kaddumukasa, Mark, Bangre, Oscar, Flach, Clare, Christiansen, Michael, Bang, Peter, Chilengi, Roma, Jepsen, Søren, Kremsner, Peter G., Theisen, Michael

Publikováno v: In Vaccine 31 August 2016 34(38):4536-4542

N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.

Autor: Ejigu, Dawit A.¹ (AUTHOR), Abay, Solomon M.² (AUTHOR)

Publikováno v: Tuberculosis Research & Treatment. 4/30/2020, p1-11. 11p. 1 Diagram, 3 Charts.

Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE):study protocol for a cluster randomised controlled trial

Autor: Asher, Laura, De Silva, Mary, Hanlon, Charlotte, Weiss, Helen A, Birhane, Rahel, Ejigu, Dawit A, Medhin, Girmay, Patel, Vikram, Fekadu, Abebaw

Publikováno v: Asher, L, De Silva, M, Hanlon, C, Weiss, H A, Birhane, R, Ejigu, D A, Medhin, G, Patel, V & Fekadu, A 2016, ' Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE) : study protocol for a cluster randomised controlled trial ', Trials, vol. 17, no. 1, pp. 299 . https://doi.org/10.1186/s13063-016-1427-9

BACKGROUND: Care for most people with schizophrenia is best delivered in the community and evidence-based guidelines recommend combining both medication and a psychosocial intervention, such as community-based rehabilitation. There is emerging eviden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::13c4c1d224d9dbac41ba2ab1bbecc752
https://kclpure.kcl.ac.uk/en/publications/412c316b-72cf-4e93-aafa-6f0d42f6f643

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

When should a time at risk start in efficacy malaria vaccine trials?

Autor: Ejigu, Dawit Asmamaw

Publikováno v: In Vaccine 5 January 2017 35(2):201-201